title: Syngeneic graft-versus-host disease after allogeneic bone marrow transplantation and cyclosporine treatment.
authors.affiliation: Johns Hopkins Bone Marrow Transplant Unit, Baltimore, MD.
authors.forename: A D
authors.initials: AD
authors.lastname: Hess
authors.forename: G B
authors.initials: GB
authors.lastname: Vogelsang
authors.forename: M
authors.initials: M
authors.lastname: Silanskis
authors.forename: K A
authors.initials: KA
authors.lastname: Friedman
authors.forename: W E
authors.initials: WE
authors.lastname: Beschorner
authors.forename: G W
authors.initials: GW
authors.lastname: Santos
mesh_terms: D000818:Animals; D001327:Autoimmune Diseases / Q000276:immunology; D016026:Bone Marrow Transplantation; D003524:Cyclosporins / Q000008:administration & dosage*; D003602:Cytotoxicity, Immunologic; D006086:Graft vs Host Disease / Q000276:immunology*; D006649:Histocompatibility Antigens / Q000276:immunology; D000949:Histocompatibility Antigens Class II / Q000276:immunology; D007111:Immunity, Cellular; D007116:Immunization, Passive; D051381:Rats
chemical_list: D003524:Cyclosporins; D006649:Histocompatibility Antigens; D000949:Histocompatibility Antigens Class II